Skip to content

Validation study of the Diabetes Treatment Burden Questionnaire (DTBQ)

Validation study of the Diabetes Treatment Burden Questionnaire (DTBQ) - Validation study of the Diabetes Treatment Burden Questionnaire (DTBQ)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026328
Enrollment
210
Registered
2017-02-28
Start date
2016-11-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Sponsors

Nara Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients are eligible only if they meet all of the following criteria: 1. Out patients (type 2 diabetes) who have pharmacotherapy >=12 weeks. 2. Male and female aged >=20 years. 3. Patients who give written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients will be excluded from the study if they meet any of the following criteria: 1. Patients who have dementia, are possibly demented, or suffered from psychiatric disorder. 2. Patients who are not competent 3. Patients who need consent from legal representative 4. Patients who are inappropriate judged by investigators in any other condition

Design outcomes

Primary

MeasureTime frame
Diabetes Treatment Burden Questionnaire (DTBQ)

Secondary

MeasureTime frame
Diabetes Treatment Satisfaction Questionaire (DTSQ)

Countries

Japan

Contacts

Public ContactHitoshi Ishii

Nara Medical University Department of Diabetology

hits1@naramed-u.ac.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026